Cargando…
Vaccine-Induced Skewing of T Cell Responses Protects Against Chikungunya Virus Disease
Chikungunya virus (CHIKV) infections can cause severe and debilitating joint and muscular pain that can be long lasting. Current CHIKV vaccines under development rely on the generation of neutralizing antibodies for protection; however, the role of T cells in controlling CHIKV infection and disease...
Autores principales: | Broeckel, Rebecca M., Haese, Nicole, Ando, Takeshi, Dmitriev, Igor, Kreklywich, Craig N., Powers, John, Denton, Michael, Smith, Patricia, Morrison, Thomas E., Heise, Mark, DeFilippis, Victor, Messaoudi, Ilhem, Curiel, David T., Streblow, Daniel N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834551/ https://www.ncbi.nlm.nih.gov/pubmed/31736977 http://dx.doi.org/10.3389/fimmu.2019.02563 |
Ejemplares similares
-
Non-replicating adenovirus based Mayaro virus vaccine elicits protective immune responses and cross protects against other alphaviruses
por: Powers, John M., et al.
Publicado: (2021) -
Nonhuman Primate Models of Chikungunya Virus Infection and Disease (CHIKV NHP Model)
por: Broeckel, Rebecca, et al.
Publicado: (2015) -
Chikungunya Virus Infection Results in Higher and Persistent Viral Replication in Aged Rhesus Macaques Due to Defects in Anti-Viral Immunity
por: Messaoudi, Ilhem, et al.
Publicado: (2013) -
Development of a next-generation chikungunya virus vaccine based on the HydroVax platform
por: Slifka, Dawn K., et al.
Publicado: (2022) -
Src Family Kinase Inhibitors Block Translation of Alphavirus Subgenomic mRNAs
por: Broeckel, Rebecca, et al.
Publicado: (2019)